Diazepam Binding Inhibitor antibody (C-Term)
Quick Overview for Diazepam Binding Inhibitor antibody (C-Term) (ABIN7184541)
Target
See all Diazepam Binding Inhibitor (DBI) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Purpose
- DBI Antibody
-
Cross-Reactivity
- Mouse, Rat
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from the C-terminal region of Human ACBP.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- Diazepam Binding Inhibitor (DBI)
-
Alternative Name
- DBI
-
Background
- ACBD 1 antibody, ACBD1 antibody, ACBP antibody, ACBP_HUMAN antibody, Acyl CoA binding domain containing 1 antibody, Acyl CoA binding protein antibody, Acyl Coenzyme A binding domain containing 1 antibody, Acyl coenzyme A binding protein antibody, Acyl-CoA-binding protein antibody, CCK RP antibody, CCKRP antibody, Cholecystokinin releasing peptide trypsin sensitive antibody, DBI antibody, Diazepam-binding inhibitor antibody, Endozepine antibody, EP antibody, GABA receptor modulator antibody, MGC70414 antibody
-
UniProt
- P07108
Target
-